Regulatory Filing Details

Filing Reference: GHL/2026-27/EXCH/35

This is a regulatory filing submitted to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosing the press release for unaudited consolidated financial results for the first quarter ended June 30, 2026.

Financial Performance Highlights - Q1 FY2027

Consolidated Results:

  • Total Income: ₹13,262 million, up 26.2% year-over-year (from ₹10,513 million in Q1FY2026)
  • EBITDA: ₹3,153 million, up 23.5% year-over-year (from ₹2,553 million in Q1FY2026)
  • EBITDA Margins: 23.8%, down 51 basis points year-over-year (from 24.3% in Q1FY2026)
  • Profit Before Tax: ₹2,133 million, up 2.5% year-over-year (from ₹2,081 million in Q1FY2026)
  • Profit After Tax: ₹1,573 million, down 1.1% year-over-year (from ₹1,590 million in Q1FY2026)
  • PAT Margins: 11.9% compared to 15.1% in Q1FY2026

Noida Hospital Performance:

  • Total Income: ₹855 million (compared to ₹525 million in Q4FY26)
  • EBITDA Loss: ₹49 million (improved from EBITDA loss of ₹236 million in Q4FY26)

EBITDA ex-Noida Performance:

  • EBITDA: ₹3,201 million, up 23.9% year-over-year
  • Margins: 25.8%

Exceptional Item Note: Q1FY26 had a non-recurring exceptional income of ₹196 million primarily due to reversal of potential interest liability on EPCG following transfer of EPCG license from MHPL to GHL.

Operational Metrics - Q1 FY2027

Bed Capacity & Utilization:

  • Operational Beds (Census): 3,037, up 22.1% year-over-year (from 2,487 in Q1FY2026)
  • Occupancy: 62.6% (63.2% in Q1FY2026, 60.9% in Q4FY2026)
  • Occupancy excluding Noida: 66%

Revenue Metrics:

  • ARPOB (Average Revenue Per Occupied Bed): ₹70,244, up 5.5% year-over-year (from ₹66,584 in Q1FY2026)
  • ARPP (Average Revenue Per Patient): ₹201,891 (compared to ₹201,795 in Q1FY2026)
  • ALOS (Average Length of Stay): 2.87 days, down 5.2% year-over-year (from 3.03 days in Q1FY2026)

Volume Growth:

  • In-patient count: Increased by 27.7% year-over-year
  • Out-patient count: Increased by 34.5% year-over-year
  • Occupied bed days: Increased by 21.1% year-over-year

Segment Performance:

  • International Patients Revenue: ₹782 million, up 23.0% year-over-year
  • OPD Pharmacy (Hospital & Retail) Revenue: ₹609 million, up 50.9% year-over-year

Key Developments During Q1 FY2027

Capacity Expansion:

  • Added 72 new beds across the network
  • 21 beds added at Lucknow facility
  • 51 beds added at Noida facility

Clinical Capabilities:

  • On-boarded 70+ doctors including 50+ senior clinicians across the Medanta network

Project Updates:

  • Guwahati Project: Scaled up plan to 650-bed super specialty hospital (from previous unspecified capacity) with total capex of ₹9,700 million due to new Guwahati bye-laws and National Building Construction Standards (NBCS) 2026 allowing increased built-up area
  • Expecting to operationalize new 80-bed cancer facility in Indore in the next few months

Management Commentary

From Mr. Pankaj Sahni, Group CEO and Director:

  • FY2027 started on a strong note with highest ever quarterly Total Income and EBITDA
  • Robust performance driven by significant growth in patient volumes and improved realizations
  • Patna and Lucknow continue consistent growth; Noida unit contributing meaningfully
  • Significant decline in EBITDA losses at Noida met expectations
  • Planning to add 2,950 beds across five greenfield projects over next few years
  • Committed to expanding network through disciplined, quality-anchored approach

Company Background

Business Overview:

  • One of the largest private multi-specialty tertiary care providers in North and East India
  • Operates under "Medanta" brand with six hospitals currently operational (Gurgaon, Indore, Ranchi, Lucknow, Patna, Noida)
  • Key specialties: cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, kidney and urology

Physical Infrastructure:

  • Operational hospitals span 5.6 million sq. ft.
  • 3,737 installed beds as on June 30, 2026
  • Five upcoming hospitals in Mumbai, Delhi (Pitampura, South Delhi), Guwahati and Varanasi

Service Capabilities:

  • Healthcare services in over 30 medical specialties
  • Over 2,400+ doctors led by highly experienced department heads

Leadership:

  • Founded by Dr. Naresh Trehan, world-renowned cardiovascular and cardiothoracic surgeon
  • Awards: Padma Bhushan, Padma Shri, Dr. B.C. Roy Award